One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)

2010 ◽  
Vol 95 (3) ◽  
pp. 433-433 ◽  
Author(s):  
M. Fernandes ◽  
P. Reddy ◽  
S. G. Shah
2007 ◽  
Vol 33 (6) ◽  
pp. 971-977 ◽  
Author(s):  
Nikolaos S. Tsiklis ◽  
George D. Kymionis ◽  
George A. Kounis ◽  
Aristofanis I. Pallikaris ◽  
Vasilios F. Diakonis ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Jing Wang ◽  
Weiqian Cao ◽  
Liming Tao

Purpose. To assess the efficacy and safety of transepithelial photorefractive keratectomy (TPRK) without mitomycin C as treatment for femtosecond laser in situ keratomileusis (FS-LASIK) corneal flap complications. Methods. Eight patients with corneal flap complications that occurred after FS-LASIK (five with eccentric flaps, two with buttonhole flaps, and one with a thick flap) were included in the study. Patients were treated with TPRK without mitomycin C between two weeks and twelve months after surgery. The postoperative manifest refraction, uncorrected distance visual acuity, and haze formation were assessed during six months of follow-up. Results. The mean manifest refractive spherical and cylinder refraction was 0.16 ± 0.26 and −0.44 ± 0.33 diopters, respectively, at six months postoperatively. The uncorrected distance visual acuity was above 20/25 in all patients after six months of follow-up. No haze formation was detected. Conclusions. TPRK without mitomycin C appears to be a safe and effective treatment for FS-LASIK corneal flap complications.


Sign in / Sign up

Export Citation Format

Share Document